In studies, gastrointestinal side effects were more common in people taking Zepbound than people taking placebo, and people taking Zepbound were more likely than those on placebo to stop treatment because of these side effects
Where available, endotoxin results are listed on the COA to verify laboratory purity
KLOW Blend is a pre-formulated 4-component research peptide complex combining GHK-Cu (50mg), BPC-157 (10mg), TB-500 (10mg), and KPV (10mg) in a single 80mg vial
Any use outside of research falls into a legal gray area
At week 72, the percentage change in weight was -15.0% with 5 mg of tirzepatide, -19.5% with 10 mg, and -20.9% with 15 mg, compared to -3.1% with the placebo
Haupt, A